JMnorm: a novel Joint Multi-feature normalization method for integrative and comparative epigenomics
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
ABSTRACT Combinatorial patterns of epigenetic features reflect transcriptional states and functions of genomic regions. While many epigenetic features have correlated relationships, most existing data normalization approaches analyze each feature independently. Such strategies may distort relationships between functionally correlated epigenetic features and hinder biological interpretation. We present a novel approach named JMnorm that simultaneously normalizes multiple epigenetic features across cell types, species, and experimental conditions by leveraging information from partially correlated epigenetic features. We demonstrate that JMnorm-normalized data can better preserve cross-epigenetic-feature correlations across different cell types and enhance consistency between biological replicates than data normalized by other methods. Additionally, we show that JMnorm-normalized data can consistently improve the performance of various downstream analyses, which include candidate cis-regulatory element clustering, cross-cell-type gene expression prediction, detection of transcription factor binding and changes upon perturbations. These findings suggest that JMnorm effectively minimizes technical noise while preserving true biologically significant relationships between epigenetic datasets. We anticipate that JMnorm will enhance integrative and comparative epigenomics. GRAPHICAL ABSTRACT JMnorm can jointly normalize multiple epigenetic features between the target sample and the reference.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- JMnorm: a novel Joint Multi-feature normalization method for integrative and comparative epigenomics
- Date Crossref
- 15/06/2023
- Éditeur
- openRxiv
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
C4 Therapeutics (United States) pays non établi dans la noticeEntreprise
-
CAMP4 Therapeutics Corp. pays non établi dans la noticeInstitution
C4 Therapeutics (United States) et CAMP4 Therapeutics Corp..
Une affiliation ne permet pas de déduire la nationalité d’un auteur.